Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea
- 22 June 2021
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 143 (25) , 2508-2510
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance StudyClinical Infectious Diseases, 2020
- Kawasaki Disease: Global Burden and Genetic BackgroundCardiology Research, 2020
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to JapanProceedings of the National Academy of Sciences, 2014
- Seasonality and Temporal Clustering of Kawasaki SyndromeEpidemiology, 2005